{
  "trial_id": "NCT02328326",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, HbA1C level, blood pressure, diabetes duration, medication use, primary care visits, cognitive impairment status, living situation, language proficiency, life-limiting illness status, mental health status, substance abuse status, pregnancy status, care partner involvement, care partner age, care partner cognitive impairment status, care partner health status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Insulin Use among Patient Participants",
          "medication use"
        ],
        [
          "Patient Baseline Patient Activation Measure (PAM-13)",
          "PAM-13 Cutoff"
        ],
        [
          "Baseline UKPDS 5-Year Cardiac Risk Score",
          "Change in Cardiac Event 5-year Risk Score, as Measured by UKPDS Risk Engine"
        ],
        [
          "Care Partner Lives with Patient Participant",
          "living situation"
        ],
        [
          "Enrolled at Hospital-based clinic (vs. community clinic site)",
          "primary care visits"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "HbA1C level",
        "blood pressure",
        "diabetes duration",
        "cognitive impairment status",
        "language proficiency",
        "life-limiting illness status",
        "mental health status",
        "substance abuse status",
        "pregnancy status",
        "care partner involvement",
        "care partner age",
        "care partner cognitive impairment status",
        "care partner health status"
      ]
    },
    "processed-gen-response": "Age, gender, HbA1C level, blood pressure, diabetes duration, medication use, primary care visits, cognitive impairment status, living situation, language proficiency, life-limiting illness status, mental health status, substance abuse status, pregnancy status, care partner involvement, care partner age, care partner cognitive impairment status, care partner health status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, Diabetes duration, Number of primary care visits, Use of diabetes medication, Family member involvement in care,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Insulin Use among Patient Participants",
          "Use of diabetes medication"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "PAM-13 Cutoff",
        "Care Partner Lives with Patient Participant",
        "Patient Baseline Patient Activation Measure (PAM-13)",
        "Baseline UKPDS 5-Year Cardiac Risk Score",
        "Enrolled at Hospital-based clinic (vs. community clinic site)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "HbA1c",
        "Diabetes duration",
        "Number of primary care visits",
        "Family member involvement in care"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, Diabetes duration, Number of primary care visits, Use of diabetes medication, Family member involvement in care"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, HbA1c, Blood Pressure, BMI, Family Member Involvement in Care, Patient Activation Measure, UKPDS Risk Engine Score,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Patient Baseline Patient Activation Measure (PAM-13)",
          "Patient Activation Measure"
        ],
        [
          "Baseline UKPDS 5-Year Cardiac Risk Score",
          "UKPDS Risk Engine Score"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Insulin Use among Patient Participants",
        "PAM-13 Cutoff",
        "Care Partner Lives with Patient Participant",
        "Enrolled at Hospital-based clinic (vs. community clinic site)"
      ],
      "remaining_candidate_features": [
        "Diabetes Diagnosis Duration",
        "HbA1c",
        "Blood Pressure",
        "BMI",
        "Family Member Involvement in Care"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Diagnosis Duration, HbA1c, Blood Pressure, BMI, Family Member Involvement in Care, Patient Activation Measure, UKPDS Risk Engine Score"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, education level, employment status, marital status, living situation, duration of diabetes, type of diabetes, HbA1C level, blood pressure, body mass index (BMI), smoking status, comorbidities, medication use, prior diabetes-related complications, family member/care partner involvement in care, patient's primary language, patient's cognitive function, patient's functional status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Insulin Use among Patient Participants",
          "medication use"
        ],
        [
          "Care Partner Lives with Patient Participant",
          "living situation"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "PAM-13 Cutoff",
        "Patient Baseline Patient Activation Measure (PAM-13)",
        "Baseline UKPDS 5-Year Cardiac Risk Score",
        "Enrolled at Hospital-based clinic (vs. community clinic site)"
      ],
      "remaining_candidate_features": [
        "education level",
        "employment status",
        "marital status",
        "duration of diabetes",
        "type of diabetes",
        "HbA1C level",
        "blood pressure",
        "body mass index (BMI)",
        "smoking status",
        "comorbidities",
        "prior diabetes-related complications",
        "family member/care partner involvement in care",
        "patient's primary language",
        "patient's cognitive function",
        "patient's functional status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, education level, employment status, marital status, living situation, duration of diabetes, type of diabetes, HbA1C level, blood pressure, body mass index (BMI), smoking status, comorbidities, medication use, prior diabetes-related complications, family member/care partner involvement in care, patient's primary language, patient's cognitive function, patient's functional status."
  }
}